
24 Mar 2016 --- OmniActive will present a poster on their OmniLean Salacia Extract Trial in Healthy Human Subjects at Experimental Biology 2016.
Vijaya Juturu Ph.D., F.A.C.N., Senior Manager of Global Scientific and Clinical Affairs, OmniActive Health Technologies Inc. will present findings from the study: "Salacia Extract Improves Post-Prandial Glucose and Insulin Response: A Randomized Double-Blind, Placebo-Controlled, Crossover Study in Healthy Volunteers" at the Experimental Biology Conference, April 2-6 in San Diego, California, USA.
OmniLean provides a comprehensive approach to achieving multiple objectives of healthy metabolism including healthy carbohydrate metabolism, fat metabolism, heart health and weight management in one convenient, low dose ingredient from a traceable, reliable supply chain.
Upcoming webinars

Pure love deserves a pure start: Solutions that give the best start from day one
dsm-firmenich

Magnesium bisglycinate in focus: why full chelation matters
Jungbunzlauer

Bifidobacteria and Healthy Ageing: New Insights into Ageing and Immunity
Morinaga












